Dexamethasone Sustained-Release Intracanalicular Insert for Control of Postoperative Inflammation After Pars Plana Vitrectomy

PURPOSE: To evaluate the safety and efficacy of a dexamethasone sustained-release intracanalicular insert (DII) (Dextenza(®) Ocular Therapeutix, Inc., Bedford, MA) for control of inflammation and pain after pars plana vitrectomy (PPV) compared to standard topical steroid therapy. METHODS: Retrospect...

Descripción completa

Detalles Bibliográficos
Autores principales: Suñer, Ivan J, Peden, Marc C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455509/
https://www.ncbi.nlm.nih.gov/pubmed/34556974
http://dx.doi.org/10.2147/OPTH.S330255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455509/
https://www.ncbi.nlm.nih.gov/pubmed/34556974
http://dx.doi.org/10.2147/OPTH.S330255

Ejemplares similares